The deaths are also partly the result of medical successes: People are living longer, and more people are surviving heart ...

Some cancer survivors who have overcome the odds are facing another diagnosis: heart damage, from chemotherapy, radiation or ...

A groundbreaking study shows how Zepbound, a popular weight loss medication, could become a key treatment for heart failure ...

The apparent benefits at 2 years observed in the nonrandomized ALT-FLOW study pave the way for a sham-controlled trial.

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

A study published in JAMA reveals AI's superiority over manual screening in heart failure trials, enhancing patient ...

Atrial fibrillation (irregular heartbeat), which causes poor blood flow, is another cardiovascular condition that can cause ...

Berlin Heals Holding AG, a late stage MedTech start up, has developed a breakthrough method and a product for the therapy of ...

Minimally invasive heart procedures like transcatheter aortic valve replacement (TAVR) and MitraClip placement to treat mitral regurgitation can improve quality of life, and even be lifesaving, for ...

The results showed that people who took sotagliflozin had a 23% lower risk of heart attacks, strokes, and death from ...

Less than 5% of hospitalized adults with type 2 diabetes received an SGLT2 inhibitor or GLP-1 before being discharged, ...

To predict arrhythmic risk in carriers of filamin C truncating variants, a novel risk predictive model was developed based on ...